Vascepa is a prescription drug that contains the active ingredient icosapent ethyl, which is used to treat high levels of triglycerides in the blood. According to the sources provided, there are certain restrictions on Vascepa assistance.

The first source, Drug Patent Watch [1], provides information on the patent status of Vascepa. It does not provide any information on restrictions on Vascepa assistance.

The second source, Vascepa's official website [2], provides information on the drug, including its uses, dosages, and side effects. The website also offers a savings card for eligible patients, which can help reduce the cost of Vascepa. However, the website does not provide any information on restrictions on Vascepa assistance.

The third source, Vascepa HCP [3], is a website designed for healthcare professionals. It provides information on access and coverage for Vascepa. According to the website, there are certain restrictions on Vascepa assistance. For example, the savings card is not available to patients who are enrolled in any state or federally funded healthcare program, including Medicare, Medicaid, VA, DoD, or TRICARE. Additionally, the savings card cannot be used by patients who are uninsured or have commercial insurance that does not cover Vascepa. The website also notes that there may be additional restrictions based on individual insurance plans.

In conclusion, while Vascepa offers a savings card to eligible patients to help reduce the cost of the drug, there are certain restrictions on Vascepa assistance. These restrictions include limitations on eligibility for the savings card based on insurance coverage and enrollment in state or federally funded healthcare programs. It is important for patients and healthcare professionals to review the specific eligibility requirements and restrictions for Vascepa assistance.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://www.vascepa.com/
[3] https://www.vascepahcp.com/access-and-coverage/